Around the Net

Novo Nordisk Apologizes For Not Disclosing Sponsorships

Novo Nordisk has issued a mea culpa for breaking the industry code by failing to disclose its sponsorship of obesity and weight management training courses for healthcare professionals that also promoted its weight loss drug. The company's branding was missing from a LinkedIn post promoting online weight loss webinars and e-learning modules that Novo Nordisk said it sponsored from February 2020 to December 2021. "The webinars, which were viewed by thousands of healthcare professionals, preferentially included positive information about Novo’s weight loss drug Saxenda that the self-regulatory watchdog deemed a 'disguised' large-scale promotional campaign," per Financial Times.

Read the whole story at Financial Times »

Next story loading loading..